UK Markets close in 40 mins

Oak Street Health, Inc. (OSH)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
25.55+1.44 (+5.97%)
As of 10:50AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 348.87
52-week low 313.29
50-day moving average 327.35
200-day moving average 323.01

Share statistics

Avg vol (3-month) 31.98M
Avg vol (10-day) 31.84M
Shares outstanding 5240.93M
Implied shares outstanding 6N/A
Float 8106.38M
% held by insiders 19.47%
% held by institutions 194.27%
Shares short (14 Jul 2022) 422.15M
Short ratio (14 Jul 2022) 413.93
Short % of float (14 Jul 2022) 419.03%
Short % of shares outstanding (14 Jul 2022) 49.19%
Shares short (prior month 14 Jun 2022) 422.23M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin -26.82%
Operating margin (ttm)-26.61%

Management effectiveness

Return on assets (ttm)-15.33%
Return on equity (ttm)-324.60%

Income statement

Revenue (ttm)1.65B
Revenue per share (ttm)7.37
Quarterly revenue growth (yoy)73.20%
Gross profit (ttm)26.3M
EBITDA -418.3M
Net income avi to common (ttm)-442.5M
Diluted EPS (ttm)-1.62
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)660M
Total cash per share (mrq)2.74
Total debt (mrq)1.1B
Total debt/equity (mrq)N/A
Current ratio (mrq)1.79
Book value per share (mrq)0.63

Cash flow statement

Operating cash flow (ttm)-259.6M
Levered free cash flow (ttm)-184.21M